Jardine Matheson is entering the Australian market via I-MED platform, advised by Allens, and listed on the LSE as part of a deal structure.
1 report, 1 independent
Updated May 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jardine Matheson is entering the Australian market via I-MED platform, advised by Allens, and listed on the LSE as part of a deal structure.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Jardine Matheson
British conglomerate that incorporated in Bermuda and headquartered in Hong Kong
Nothing else this week.
-
London Stock Exchange
stock exchange in the City of London
Related events
- A company is considering an IPO on the LSE, with Aviva involved as the company invests in the US medical imaging market.
- Siemens Healthineers' Advanced Imaging division is winning contracts under UK Government frameworks and tracking its share price on the LSE.
- LSE resumed trading of its receipts on July 4, 2026, involving pharmaceutical peers like Beximco Pharma.
- Brooks Macdonald Group is listing and trading on the London Stock Exchange platform today, September 4, 2026.
- Bluebird Mining Ventures Ltd admitted its shares to trading on the London Stock Exchange Main Market.